Financhill
Back

Cronos Group 10K Form

Sell
18

CRON
Cronos Group

Last Price:
$1.75
Seasonality Move:
-6.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive CRON News And Ratings

See the #1 stock for the next 7 days that we like better than CRON

CRON Financial Statistics

Sales & Book Value

Annual Sales: $117.6M
Cash Flow: $4M
Price / Cash Flow: 117.81
Annual Sales: $2.78
Price / Book: 0.63

Profitability

EPS (TTM): 0.11000
Net Income (TTM): $41.1M
Gross Margin: $25.2M
Return on Equity: 3.76%
Return on Assets: 3.61%

Cronos Group Earnings Forecast

Key Cronos Group Financial Ratios

  • The Gross Profit Margin over the past 11 years for CRON is 21.42%.
  • The Selling, General & Administrative Expenses for CRON have been equal to 65.31% of Gross Profit Margin.
  • The Research & Development expenses have been 3.60% of Revenue.
  • The Net Earning history of CRON is 34.93% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 6 years.

Cronos Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CRON
CUSIP: 22717L
Website: thecronosgroup.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 18.84
Quick Ratio: 17.88

Price-to-Earnings

Trailing P/E Ratio: 15.91
Forward P/E Ratio: 0

CRON Technical Analysis vs Fundamental Analysis

Sell
18
Cronos Group (CRON) is a Sell

Is Cronos Group a Buy or a Sell?

  • Cronos Group stock is rated a Sell
    The current Cronos Group [CRON] share price is $1.75. The Score for CRON is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.